Skip to content
Categories
Satellite Symposium
Satellite Symposium
Satellite Symposium

Focus on QoL and tolerability in CML-CP: Status, limitations and latest advances

- , Kairo 1-2

Schedule Slot

Focus on QoL and tolerability in CML-CP: Status, limitations and latest advances

Categories
Satellite Symposium
Satellite Symposium
Satellite Symposium

Focus on QoL and tolerability in CML-CP: Status, limitations and latest advances

- , Kairo 1-2

Endorsed by: Novartis Pharma Schweiz AG

Chair:
Stefan Balabanov (Universitätsspital Zürich)
Daniela Žáčková

  1. Welcome & Introduction

    Presentation time:
    5 min

  2. Welcome & Introduction

    Presentation time:
    5 min

    Chair: Stefan Balabanov (Universitätsspital Zürich) , Daniela Žáčková

  3. Review of QoL situation and recent advances

    Presentation time:
    15 min

    Speaker: Jakob Passweg (Basel University Hospital)

  4. QoL & tolerability updates from Asciminib phase III study program: ASC4FIRST

    Presentation time:
    20 min

    Speaker: Natalia Baran

  5. QoL & tolerability updates from Asciminib phase III study program: ASC4START

    Presentation time:
    10 min

    Speaker: Stefan Balabanov (Universitätsspital Zürich)

  6. Panel Discussion and Q&A

    Presentation time:
    10 min